Part,  Chapter, Paragraph

 1   II,     5.  8.  7|          of Airway Disease. Am. J. Respir. Crit. Care Med. 167: 787-
 2   II,     5.  8.  7|      exposed to inorganic dust~Eur Respir J 23: 402-406.~ ~Bilde L,
 3   II,     5.  8.  7|            with non-COPD controls. Respir Med 2007; 101: 539-546.~ ~B N (
 4   II,     5.  8.  7|          Respiratory Diseases.~Eur Respir J 2007; 29: 233-239.~ ~Boutin-Forzano
 5   II,     5.  8.  7|            ERS position paper. Eur Respir J 2004; 23: 932-946.~ ~Cerveri
 6   II,     5.  8.  7|        phlegm in young adults. Eur Respir J 2003; 22: 413-417.~ ~Chapman
 7   II,     5.  8.  7| obstructive pulmonary disease. Eur Respir J 2006; 27: 188-207.~ ~Dal
 8   II,     5.  8.  7|           Confronting COPD survey. Respir Med 2003; 97: s43-50.~ ~
 9   II,     5.  8.  7|            pulmonary disease. Am J Respir Crit Care Med 2003; 167:
10   II,     5.  8.  7|            last 12 months of life. Respir Med 102:885-891~ ~GOLD (
11   II,     5.  8.  7|        treatment and co-morbidity. Respir Res 2006; 7: 109-116.~ ~
12   II,     5.  8.  7|      review and meta-analysis. Eur Respir J 2006; 28: 523-532.~ ~Hansell
13   II,     5.  8.  7|         cause coding analysis. Eur Respir J 2003; 22: 809-814.~ ~Jansson
14   II,     5.  8.  7|           a cross sectional study. Respir Med 2007; 101: 177-185.~ ~
15   II,     5.  8.  7|           Northern Sweden Studies. Respir Med 2006; 100: 264-272.~ ~
16   II,     5.  8.  7|           Northern Sweden Studies. Respir Med 2003; 97: 115122.~ ~
17   II,     5.  8.  7|       research in Europe: FP7. Eur Respir J 2007; 29: 223-225.~ ~Mannino
18   II,     5.  8.  7|          among general population. Respir Med 2006; 100: 1973-1980.~ ~
19   II,     5.  8.  7|     disease”. Siafakas NM eds. Eur Respir Mon, Monograph 38, 2006;
20   II,     5.  8.  7|   Exposures in Young Adults Am. J. Respir. Crit. Care Med. 172:1139-
21   II,     5.  8.  7|  population of patients with COPD. Respir Med 2006; 100: 1349-1355.~ ~
22   II,     5.  8.  7|       natural history of COPD. Eur Respir J 2007; 30: 993–1013~ ~Vrbica
23   II,     5.  8.  7|     Increasing COPD awareness. Eur Respir J 2006; 27: 833-852.~ ~Zock
24   II,     5.  8.  7|         International Study Am. J. Respir. Crit. Care Med. 163:1572-
25   II,     5.  9.  4|           unclear (Landau Paediatr Respir Rev, 2008).~ ~Outdoor air
26   II,     5.  9.  7|           The costs of asthma. Eur Respir J. 2006 Apr;9(4):636-42~ ~Bj P (
27   II,     5.  9.  7|      children with asthma. Rev Mal Respir. 2002 Oct;19(5 Pt 1):585-
28   II,     5.  9.  7|     Respiratory Diseases). Rev Mal Respir.Sep; 23 (4 Pt 2):10S73-10S75~ ~
29   II,     5.  9.  7|     Respiratory Health Survey. Eur Respir J, 1994, 7, 954-960~ ~Compalati
30   II,     5.  9.  7|            Steering Committee. Eur Respir J 2002; 20:1071-1079~ ~Fasce
31   II,     5.  9.  7|          into adult life. Paediatr Respir Rev. 2008 Mar;9(1):39-44.
32   II,     5.  9.  7|   predictors: the RHINE study. Eur Respir J 2004; 24: 942-946~ ~To E,
33   II,     5. 10.  7|      symptoms in young adults. Eur Respir J 1998; 11(1):151-155.~ ~
34  III,    10.  2.  1|     Respiratory Health Survey. Eur Respir J 2006; 27:517-524~ ~Joossens